Expression of fatty acid synthase (FASN) in oral nevi and melanoma

Oral Diseases

Volumn 17, Issue 8, 2011, Pages 808-812

  De Andrade, Bab ^a   León, Je ^a   Carlos, R ^b   Delgado Azanero W ^c   Mosqueda Taylor, A ^d   Graner, E ^a   de Almeida, Op ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Centro Clinico de Cabeza y Cuello/Hospital Herrera Llerandi   (Guatemala)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^d DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Fatty acid synthase; Immunohistochemistry; Melanocytic nevi; Melanoma; Mouth

Indexed keywords

FATTY ACID SYNTHASE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOCYTIC NEVUS; MELANOMA; MOUTH DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; COLORING AGENTS; FATTY ACID SYNTHETASE COMPLEX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOCYTES; MELANOMA; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEVUS; NEVUS, INTRADERMAL; NEVUS, PIGMENTED; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 80054063737     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01841.x     Document Type: Article

References (32)

1. Allen CM, Pellegrini A (1995). Probable congenital melanocytic nevus of the oral mucosa: case report. Pediatr Dermatol 12: 145-148.
2. Alli PM, Pinn ML, Jaffee EM, McFadden JM, Kuhajda FP (2005). Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice. Oncogene 24: 39-46.
3. Baron A, Migita T, Tang D, Loda M (2004). Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem 91: 47-53.
4. Breslow A (1970). Thickness, cross-sectional areas, and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172: 902-908.
5. Carvalho MA, Zecchin KG, Seguin F et al (2008). Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model. Int J Cancer 123: 2557-2565.
6. Femiano F, Lanza A, Buonaiuto C, Gombos F, Di Spirito F, Cirillo N (2008). Oral malignant melanoma: a review of the literature. J Oral Pathol Med 37: 383-388.
7. Gansler TS, Hardman W 3rd, Hunt DA, Schaffel S, Hennigar RA (1997). Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 28: 686-692.
8. Heemers H, Maes B, Foufelle F, Heyns W, Verhoeven G, Swinnen JV (2001). Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol 10: 1817-1828.
9. Innocenzi D, Alo PL, Balzani A et al (2003). Fatty acid synthase expression in melanoma. J Cutan Pathol 30: 23-28.
10. Jayakumar A, Tai MH, Huang WY et al (1995). Human fatty acid synthase: properties and molecular cloning. Proc Natl Acad Sci 92: 8695-8699.
11. Kapur P, Rakheja D, Roy LC, Hoang MP (2005). Fatty acid synthase expression in cutaneous melanocytic neoplasms. Mod Pathol 18: 1107-1112.
12. Kridel SJ, Axelrod F, Rozenkrantz N, Smith JW (2004). Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res 64: 2070-2075.
13. Kuhajda FP (2000). Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16: 202-208.
14. Kusakabe T, Maeda M, Hoshi N et al (2000). atty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells. J Histochem Cytochem 48: 613-622.
15. Kusakabe T, Nashimoto A, Honma K, Suzuki T (2002). Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology 40: 71-79.
16. Lacasa D, Le Liepvre X, Ferre P, Dugail I (2001). Progesterone stimulates adipocyte determination and differentiation 1/sterol regulatory element-binding protein 1c gene expression: potential mechanism for the lipogenic effect of progesterone in adipose tissue. J Biol Chem 15: 11512-11516.
17. Li JN, Gorospe M, Chrest FJ et al (2001). Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res 61: 1493-1499.
18. Meleti M, Mooi WJ, Casparie MK, van der Waal I (2007). Melanocytic nevi of the oral mucosa - no evidence of increased risk for oral malignant melanoma: an analysis of 119 cases. Oral Oncol 43: 976-981.
19. Prasad ML, Patel S, Hoshaw-Woodard S et al (2002). Prognostic factors for malignant melanoma of the squamous mucosa of the head and neck. Am J Surg Pathol 26: 883-892.
20. Prasad ML, Patel SG, Huvos AG, Shah JP, Busam KJ (2004). Primary mucosal melanoma of the head and neck. A proposal for microstaging localized, stage I (lymphnode-negative) tumors. Cancer 100: 1657-1664.
21. Rose C, Kaddu S, El-sherif TF, Kerl H (2003). A distinctive type of widespread congenital melanocytic nevus with large nodules. J Am Acad Dermatol 49: 732-735.
22. Rossi S, Graner E, Febbo P et al (2003). Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res 1: 707-715.
23. Shurbaji MS, Kalbfleisch JH, Thurmond TS (1996). Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol 27: 917-921.
24. Silva SD, Agostini M, Nishimoto IN et al (2004). Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study. Oral Oncol 40: 688-696.
25. Silva SD, Perez DE, Nishimoto IN et al (2008). Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings. Oral Dis 14: 376-382.
26. da Silva SD, Cunha IW, Nishimoto IN et al (2009). Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas. Oral Oncol 45: 134-139.
27. Swinnen JV, Roskams T, Joniau S et al (2002). Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer 98: 19-22.
28. Takahiro T, Shinichi K, Toshimitsu S (2003). Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas. Clin Cancer Res 9: 2204-2212.
29. Uchiyama N, Yamamoto A, Kameda K, Yamaguchi H, Ito M (2000). The activity of fatty acid synthase of epidermal keratinocytes is regulated in the lower stratum spinousum and the stratum basale by local inflammation rather than by circulating hormones. J Dermatol Sci 24: 134-141.
30. Visca P, Sebastiani V, Pizer ES et al (2003). Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma. Anticancer Res 23: 335-339.
31. Weiss L, Hoffmann GE, Schreiber R et al (1986). Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol Chem Hoppe Seyler 367: 905-912.
32. Zhou W, Simpson PJ, McFadden JM et al (2003). Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. Cancer Res 63: 7330-7337.